$72.46
1.33% yesterday
NYSE, May 08, 10:15 pm CET
ISIN
US3795772082
Symbol
GMED

Globus Medical, Inc. Class A Stock price

$72.46
+3.82 5.57% 1M
-8.42 10.41% 6M
-10.25 12.39% YTD
+10.73 17.38% 1Y
+11.99 19.83% 3Y
+22.95 46.35% 5Y
+47.56 191.00% 10Y
NYSE, Closing price Thu, May 08 2025
+0.95 1.33%
ISIN
US3795772082
Symbol
GMED
Sector

Key metrics

Market capitalization $9.81b
Enterprise Value $9.46b
P/E (TTM) P/E ratio 97.34
EV/FCF (TTM) EV/FCF 23.33
EV/Sales (TTM) EV/Sales 3.75
P/S ratio (TTM) P/S ratio 3.89
P/B ratio (TTM) P/B ratio 2.38
Revenue growth (TTM) Revenue growth 60.62%
Revenue (TTM) Revenue $2.52b
EBIT (operating result TTM) EBIT $244.91m
Free Cash Flow (TTM) Free Cash Flow $405.21m
Cash position $890.06m
EPS (TTM) EPS $0.74
P/E forward 24.43
P/S forward 3.66
EV/Sales forward 3.53
Short interest 4.12%
Show more

Is Globus Medical, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,791 stocks worldwide.

Globus Medical, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Globus Medical, Inc. Class A forecast:

13x Buy
76%
4x Hold
24%

Analyst Opinions

17 Analysts have issued a Globus Medical, Inc. Class A forecast:

Buy
76%
Hold
24%

Financial data from Globus Medical, Inc. Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,519 2,519
61% 61%
100%
- Direct Costs 1,155 1,155
93% 93%
46%
1,365 1,365
41% 41%
54%
- Selling and Administrative Expenses 727 727
47% 47%
29%
- Research and Development Expense 139 139
12% 12%
5%
499 499
43% 43%
20%
- Depreciation and Amortization 254 254
76% 76%
10%
EBIT (Operating Income) EBIT 245 245
20% 20%
10%
Net Profit 103 103
16% 16%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Globus Medical, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Globus Medical, Inc. Class A Stock News

Neutral
Seeking Alpha
about 6 hours ago
Globus Medical, Inc. (NYSE:GMED ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development & IR Dan Scavilla - President & CEO Keith Pfeil - COO & CFO Conference Call Participants Matt Miksic - Barclays Vik Chopra - Wells Fargo Richard Newitter - Truist Securities Matthew Blackman - Stifel Shagun Singh - RBC Caitlin Cronin - Canaccord...
Neutral
GlobeNewsWire
about 12 hours ago
AUDUBON, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2025.
Neutral
GlobeNewsWire
22 days ago
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2025 after the market close on Thursday, May 8, 2025. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
More Globus Medical, Inc. Class A News

Company Profile

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Head office United States
CEO Daniel Scavilla
Employees 5,300
Founded 2003
Website www.globusmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today